Aprea Therapeutics, Inc. (17)
Browse by Contract Category
Contracts
-
Companion Diagnostic Agreement dated August 11, 2020, by and between Invivoscribe, Inc. and the Registrant
(Filed With SEC on August 11, 2020)
-
Description of the Companys Common Stock, $0.001 par value
(Filed With SEC on March 27, 2020)
-
Form of 2019 Stock Incentive Plan and form of agreements thereunder
(Filed With SEC on September 27, 2019)
-
Master Manufacturing and Supply Agreement, between Aprea Therapeutics AB and Siegfried Hameln GmbH
(Filed With SEC on September 25, 2019)
-
Employment Agreement between the Registrant and Scott M. Coiante
(Filed With SEC on September 27, 2019)
-
Employment Agreement between the Registrant and Gregory A. Korbel, Ph.D
(Filed With SEC on September 27, 2019)
-
Employment Agreement between the Registrant and Lars Abrahmsen, Ph.D
(Filed With SEC on September 27, 2019)
-
Form of Executive Employment Agreement
(Filed With SEC on September 27, 2019)
-
Employment Agreement between the Registrant and Christian S. Schade
(Filed With SEC on September 27, 2019)
-
Specimen common stock certificate of the Registrant
(Filed With SEC on September 27, 2019)
-
Form of Amended and Restated Registration Rights Agreement, by and among the Registrant and the shareholders party thereto
(Filed With SEC on September 25, 2019)
-
Service Agreement, between Aprea AB and Syngene International Private Limited
(Filed With SEC on September 25, 2019)
-
Form of 2019 Employee Stock Purchase Plan and form of agreements thereunder
(Filed With SEC on September 25, 2019)
-
Form of 2019 Stock Incentive Plan and form of agreements thereunder
(Filed With SEC on September 25, 2019)
-
Service Agreement, between Aprea AB and Syngene International Private Limited
(Filed With SEC on September 23, 2019)
-
APREA THERAPEUTICS, INC. DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT
(Filed With SEC on September 23, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on September 23, 2019)